Preferred Name |
azilsartan medoxomil |
|
Synonyms |
TAK-491 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C557413 |
|
altLabel |
TAK-491 1H-benzimidazole-7-carboxylic acid, 1-((2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester TAK 491 TAK491 |
|
cui |
C2698291 C3252897 |
|
HM |
D010069 D001562 |
|
Inverse of RB |
LL0G25K7I2 |
|
isa | ||
Mapped to | ||
MDA |
20110413 |
|
MeSH Frequency |
78 |
|
MMR |
20170801 |
|
notation |
C557413 |
|
PA |
D047228 |
|
prefLabel |
azilsartan medoxomil |
|
SC |
1 |
|
Scope Statement |
an azilsartan prodrug and angiotensin II type 1 receptor blocker |
|
SRC |
Hypertension 2011 Mar;57(3):413-20 |
|
TERMUI |
T788902 T814506 T814508 T814507 |
|
TH |
FDA SRS (2017) NLM (2012) INN (19XX) USAN (2007) |
|
tui |
T109 T121 |
Create mapping